A Randomised, Controlled Study of Different Glycaemic Targets during Gestational Diabetes Treatment: Effect on the Level of Adipokines in Cord Blood and ANGPTL4 Expression in Human Umbilical Vein Endothelial Cells

Table 1

Characteristics of the participants at study entry.

	GDM 1; ()	GDM2; ()	Control; ()		control-GDM1	control-GDM2	GDM1-GDM2
Maternal age, years	30.9 ± 5.4	32.3 ± 5.0	30.8 ± 4.2	0.566
Prepregnancy BMI, kg/m^2	25.4 ± 7.2	26.1 ± 6.5	23.4 ± 4.2	0.287
BP syst, mmHg	120 ± 13	118 ± 12	112 ± 14	0.114
BP diast, mmHg	76 ± 8	73 ± 10	69 ± 8	0.016	0.003	0.155	0.195
Fasting PG, mmol/L	5.1 ± 0.8	5.0 ± 0.6	4.5 ± 0.4	0.007	0.004	0.003	0.396
OGTT 1 h PG, mmol/L	10.2 ± 1.4	9.9 ± 1.6	6.9 ± 1.9	<0.001	<0.001	<0.001	0.454
OGTT 2 h PG, mmol/L	8.0 ± 1.6	8.8 ± 1.6	5.9 ± 1.5	<0.001	<0.001	<0.001	0.231
Fasting leptin, ng/mL	22.2 ± 20.7	29.5 ± 26.2	26.6 ± 17.0	0.561
Fasting adiponectin, ng/mL	7.2 ± 3.3	9.1 ± 3.3	8.9 ± 2.5	0.077

Note: BMI: body mass index; BP: blood pressure; PG: plasma glucose; OGTT: oral glucose tolerance test.